Role of the T3SS effector protein IcsB in Shigella flexneri infection

NIH RePORTER · NIH · F31 · $26,325 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT Shigella flexneri is a human pathogen that causes shigellosis, a severe diarrheal disease. S. flexneri invades the colonic mucosa where it replicates in the cytosol of epithelial cells and spreads from cell to cell. This dissemination process relies on cytosolic actin-based motility and formation of membrane protrusions that project into adjacent cells. The resolution of these membrane protrusions leads to formation of double membrane vacuoles (DMVs), from which the bacteria subsequently escape, thereby gaining access to the cytosolic compartment of adjacent cells. Our lab has shown that the S. flexneri type three secretion system (T3SS) is required at multiple stages of the dissemination process, including protrusion resolution and double membrane DMV escape. I have shown recently that the T3SS effector protein IcsB contributes to S. flexneri dissemination by promoting prompt and efficient escape from DMVs. Here, I propose to determine the mechanism by which IcsB facilitates DMV escape (Aim 1) and its relevance to pathogenesis in our recently developed infant rabbit model of human shigellosis (Aim 2). My central hypothesis is that IcsB is a critical virulence factor that manipulates host Rho GTPases to promote prompt and efficient DMV escape. Since S. flexneri dissemination is a critical determinant of pathogenesis, my work may reveal novel therapeutic intervention for treating human shigellosis.

Key facts

NIH application ID
10231053
Project number
5F31AI143139-03
Recipient
UNIVERSITY OF VIRGINIA
Principal Investigator
Erin A Weddle
Activity code
F31
Funding institute
NIH
Fiscal year
2021
Award amount
$26,325
Award type
5
Project period
2019-09-01 → 2022-05-31